WO2007132439A1 - Long acting deodorant composition - Google Patents

Long acting deodorant composition Download PDF

Info

Publication number
WO2007132439A1
WO2007132439A1 PCT/IL2006/000566 IL2006000566W WO2007132439A1 WO 2007132439 A1 WO2007132439 A1 WO 2007132439A1 IL 2006000566 W IL2006000566 W IL 2006000566W WO 2007132439 A1 WO2007132439 A1 WO 2007132439A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
deodorant
urea
long lasting
formulation
Prior art date
Application number
PCT/IL2006/000566
Other languages
French (fr)
Inventor
Philip Hlavin
Original Assignee
Hlavin Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hlavin Industries Ltd. filed Critical Hlavin Industries Ltd.
Priority to PCT/IL2006/000566 priority Critical patent/WO2007132439A1/en
Priority to JP2006156434A priority patent/JP2006335761A/en
Publication of WO2007132439A1 publication Critical patent/WO2007132439A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/0229—Sticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging
    • A61K2800/874—Roll-on

Definitions

  • the present invention relates to compositions and in particular to deodorant formulations having long term effectiveness.
  • Deodorant compositions typically are provided in a deodorant spray, as a cream or roll on dry liquid or within a waxy stick, and these are effective to a greater or lesser extent, but mostly have an effect lasting less than a number of hours, and typically no more than 24 hours and often considerably less.
  • WO0024370 describes dermatologic gels for the treatment of acne vulgaris and herpes simplex containing methenamine. No reference is made to using this material in deodorants however.
  • WO02074279A2 describes a formulation for treating body odor, in particular foot odor.
  • the formulation comprises a combination of hexamine and zinc oxide or pharmaceutically acceptable salts thereof.
  • the formulation is preferably an aqueous formulation, but it may be a powder formulation.
  • Other ingredients of preferred compositions thereof include glycerol and talc.
  • polyhexamethylene biguanide Another known antimicrobial agent is polyhexamethylene biguanide.
  • US Patent Application No.2004008295 describes a medical dressing useful in healing of wounds including polyhexamethylene biguanide as an antimicrobial agent.
  • EPl 216691 describes an antibacterial composition comprising a synergistic mixture of a fragrance aldehyde and a preservative.
  • One composition discussed, and having antibacterial effect includes polyaminopropyl biguanide.
  • US 6,010,687 discloses a deodorant composition for topical application to human skin which is characterized in that it comprises an effective amount of polyhexamethylene biguanide and an effective amount of chlorhexidine in a cosmetically acceptable carrier.
  • IL Patent Application No.164640 by the present applicant claims a long lasting deodorant composition comprising a synergistic combination of polyaminopropyl biguanide and methenamine.
  • Another object of the invention is to provide a long lasting deodorant composition in the form of a cream.
  • Another object of the invention is to provide a long lasting deodorant composition in the form of a stick.
  • Another object of the invention is to provide a long lasting deodorant composition in the form of a roll-on.
  • Another object of the invention is to provide a long lasting deodorant composition in the form of a spray.
  • a further object of the invention is to provide a deodorant composition that gives odor free protection for 4 to 7 days.
  • deodorant formulations containing urea, imidazolidinyl urea, or the salts of ethylenediaminetetraacedic acid (EDTA), particularly the tetrasodiun salt have long lasting deodorant effects especially when used together with ethylhexylglycerin and/or O-cymen-5-ol.
  • EDTA ethylenediaminetetraacedic acid
  • deodorant compositions of the present invention are readily detectable by comparing the odor of an untreated armpit to a treated armpit of the same subject.
  • Ethylhexylglycerin is known to have deodorant properties. But these are short lived, less than 24 hours. When, however, urea and/or EDTA tetrasodium salt is added to a formulation containing ethylhexylglycerin the deodorant protection is extended to between 5-7 days.
  • a long lasting deodorant composition comprising a deodorant base formulation and between 0.1% and 30% of either urea, imidazolidinyl urea or EDTA salt, or any mixture of them.
  • composition there is included l%-8% ethylhexylglycerin.
  • Another preferred composition includes 0.01% to 5% O-Cymen-5-ol.
  • the deodorant composition comprises between 0.3% to 10% urea or imidazolidinyl urea and /or EDTA salt.
  • a most preferred formulation contains 0.1% to 5% urea or imidazolidinyl urea and 0.1% to 5% EDTA salt and 0.05% to 0.5% O-Cymen-5-ol.
  • a most preferred formulation contains 0.1% to 5% urea or imidazolidinyl urea and/or 0.1% to 5% EDTA salt
  • the O-Cymen-5-ol can have a concentration of 0.05% to 0.5%, and preferably between 0.03% to 1%..
  • composition of this invention may be applied to the armpit and gives a long lasting deodorant effect for up to 5 to 7 days.
  • the deodorant formulation comprises about 1% urea or imidazoli dinyl urea and /or 1% tetrasodium EDTA .
  • the deodorant composition can be formulated in any of the conventional form, such as a cream, a stick, a roll-on or spray.
  • the base deodorant formulations can of course vary, and may include natural creams and oils, fragrances, humectants and powders such as Talc, starch, zinc oxide, as long as the cosmetic cream base is compatible with the active ingredients.
  • Some of the ingredients that we found satisfactory for deodorant formulations are petrolatum, talc, Zinc oxide, potato starch, rice starch, triethyl citrate, chamomile oil, arnica oil, calendula oil, BHT, chlorphenesin, propylene glycol, sodium stearate, ethylhexylgrycerin, cremofor, panthenol, hydroxyethyl cellulose, O-Cymen-5-ol and fragrance.
  • Example 1 Long lasting deodorant cream
  • Example 1 The formulation of Example 1 was tested on 10 people and gave deodorant protection of from 5-7 days whereas without the tetrasodiun EDTA, protection lasted for less than 24 hours.
  • Example 2 The formulation of Example 2 was tested on 10 people and gave deodorant protection of from 4-7 days whereas without the urea and tetrasodiun EDTA, protection lasted for less than 24 hours, and with either urea or tetrasodiun EDTA alone protection lasted 2-3 days.
  • Example 3 The formulation of Example 3 was tested on 11 people and gave deodorant protection of from 4-7 days whereas without the urea and tetrasodiun EDTA, protection lasted for less than 24 hours, and with either urea or tetrasodiun EDTA alone protection lasted 2-3 days.
  • Example 4 The formulation of Example 4 was tested on 11 people and gave deodorant protection of from 4-7 days whereas without the urea and tetrasodiun EDTA, protection lasted for less than 24 hours, and with either urea or tetrasodiun EDTA alone protection lasted 2-3 days.
  • Example 5 The formulation of Example 5 was tested on 10 people and gave deodorant protection of from 5-7 days whereas a control gave protection that lasted less than 24 hours.
  • Example 6 The formulation of Example 6 was tested on 9 people and gave deodorant protection of from 4-7 days whereas a control group had protection that lasted for less than 24 hours, and with either imidazolidinyl urea or tetrasodiun EDTA alone protection lasted 2-3 days.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

A long lasting deodorant composition comprising a cosmetically acceptable base formulation containing from 0.1% to 30% of a compound selected from urea, imidazolidinyl urea or a cosmetically acceptable EDTA salt.

Description

4-
LONG ACTING DEODORANT COMPOSITION
FIELD OF THE INVENTION
The present invention relates to compositions and in particular to deodorant formulations having long term effectiveness.
BACKGROUND OF THE INVENTION
There are a number of malodor forming skin bacteria, such as corynebacteria, that react with lymph gland secretions to produce body odour, and there is much prior art relating to deodorant compositions.
Deodorant compositions typically are provided in a deodorant spray, as a cream or roll on dry liquid or within a waxy stick, and these are effective to a greater or lesser extent, but mostly have an effect lasting less than a number of hours, and typically no more than 24 hours and often considerably less.
Many conventional deodorants are also antiperspirants and they work by blocking the sweat glands in the underarm reason where they are applied. There are some antibacterial agents that have been used in deodorant compositions.
WO0024370 describes dermatologic gels for the treatment of acne vulgaris and herpes simplex containing methenamine. No reference is made to using this material in deodorants however.
WO02074279A2 describes a formulation for treating body odor, in particular foot odor. The formulation comprises a combination of hexamine and zinc oxide or pharmaceutically acceptable salts thereof. The formulation is preferably an aqueous formulation, but it may be a powder formulation. Other ingredients of preferred compositions thereof include glycerol and talc.
Another known antimicrobial agent is polyhexamethylene biguanide. For example, US Patent Application No.2004008295 describes a medical dressing useful in healing of wounds including polyhexamethylene biguanide as an antimicrobial agent.
EPl 216691 describes an antibacterial composition comprising a synergistic mixture of a fragrance aldehyde and a preservative. One composition discussed, and having antibacterial effect includes polyaminopropyl biguanide.
US 6,010,687 discloses a deodorant composition for topical application to human skin which is characterized in that it comprises an effective amount of polyhexamethylene biguanide and an effective amount of chlorhexidine in a cosmetically acceptable carrier.
IL Patent Application No.164640 by the present applicant claims a long lasting deodorant composition comprising a synergistic combination of polyaminopropyl biguanide and methenamine.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide a long lasting deodorant composition in a single application.
Another object of the invention is to provide a long lasting deodorant composition in the form of a cream.
Another object of the invention is to provide a long lasting deodorant composition in the form of a stick.
Another object of the invention is to provide a long lasting deodorant composition in the form of a roll-on.
Another object of the invention is to provide a long lasting deodorant composition in the form of a spray.
A further object of the invention is to provide a deodorant composition that gives odor free protection for 4 to 7 days.
DETAILED DESCRIPTION OF THE INVENTION It has been surprisingly found that deodorant formulations containing urea, imidazolidinyl urea, or the salts of ethylenediaminetetraacedic acid (EDTA), particularly the tetrasodiun salt, have long lasting deodorant effects especially when used together with ethylhexylglycerin and/or O-cymen-5-ol.
These materials have long lasting deodorant activity even when used independently in a formulation, however, in combination they exhibit a very marked increase in long term deodorant protection. This effect is valid for people of different physiologies, including age, sex and ethnicity. Typically a single application provides a deodorant effect noticeable even up to seven days later. The effectiveness of deodorant compositions of the present invention is readily detectable by comparing the odor of an untreated armpit to a treated armpit of the same subject.
Ethylhexylglycerin is known to have deodorant properties. But these are short lived, less than 24 hours. When, however, urea and/or EDTA tetrasodium salt is added to a formulation containing ethylhexylglycerin the deodorant protection is extended to between 5-7 days.
In accordance with this invention there is thus provided a long lasting deodorant composition comprising a deodorant base formulation and between 0.1% and 30% of either urea, imidazolidinyl urea or EDTA salt, or any mixture of them.
In a preferred composition there is included l%-8% ethylhexylglycerin. Another preferred composition includes 0.01% to 5% O-Cymen-5-ol.
In a preferred formulation the deodorant composition comprises between 0.3% to 10% urea or imidazolidinyl urea and /or EDTA salt.
A most preferred formulation contains 0.1% to 5% urea or imidazolidinyl urea and 0.1% to 5% EDTA salt and 0.05% to 0.5% O-Cymen-5-ol. A most preferred formulation contains 0.1% to 5% urea or imidazolidinyl urea and/or 0.1% to 5% EDTA salt
The O-Cymen-5-ol can have a concentration of 0.05% to 0.5%, and preferably between 0.03% to 1%..
To the best of our knowledge there does not exist a cream deodorant composition that is effective for more than 2 to 3 days, whereas the composition of this invention may be applied to the armpit and gives a long lasting deodorant effect for up to 5 to 7 days.
The relative proportions of urea, imidazolidinyl urea and EDTA salt may vary, but the antibacterial effect is already noticeable with quantities as little as 0.3% of each.
In a preferred embodiment the deodorant formulation comprises about 1% urea or imidazoli dinyl urea and /or 1% tetrasodium EDTA .
As stated previously, the deodorant composition can be formulated in any of the conventional form, such as a cream, a stick, a roll-on or spray.
The base deodorant formulations can of course vary, and may include natural creams and oils, fragrances, humectants and powders such as Talc, starch, zinc oxide, as long as the cosmetic cream base is compatible with the active ingredients. Some of the ingredients that we found satisfactory for deodorant formulations are petrolatum, talc, Zinc oxide, potato starch, rice starch, triethyl citrate, chamomile oil, arnica oil, calendula oil, BHT, chlorphenesin, propylene glycol, sodium stearate, ethylhexylgrycerin, cremofor, panthenol, hydroxyethyl cellulose, O-Cymen-5-ol and fragrance.
The following examples will best illustrate the invention. Example 1 : Long lasting deodorant cream
Figure imgf000005_0001
Figure imgf000006_0001
The formulation of Example 1 was tested on 10 people and gave deodorant protection of from 5-7 days whereas without the tetrasodiun EDTA, protection lasted for less than 24 hours.
Example 2- Long lasting deodorant stick
Figure imgf000006_0002
The formulation of Example 2 was tested on 10 people and gave deodorant protection of from 4-7 days whereas without the urea and tetrasodiun EDTA, protection lasted for less than 24 hours, and with either urea or tetrasodiun EDTA alone protection lasted 2-3 days.
Example 3- Long lasting deodorant Roll-On
Figure imgf000007_0001
The formulation of Example 3 was tested on 11 people and gave deodorant protection of from 4-7 days whereas without the urea and tetrasodiun EDTA, protection lasted for less than 24 hours, and with either urea or tetrasodiun EDTA alone protection lasted 2-3 days.
Example 4- Long lasting deodorant Spray
Figure imgf000007_0002
Figure imgf000008_0001
The formulation of Example 4 was tested on 11 people and gave deodorant protection of from 4-7 days whereas without the urea and tetrasodiun EDTA, protection lasted for less than 24 hours, and with either urea or tetrasodiun EDTA alone protection lasted 2-3 days.
Example 5: Long lasting deodorant cream
Figure imgf000008_0002
The formulation of Example 5 was tested on 10 people and gave deodorant protection of from 5-7 days whereas a control gave protection that lasted less than 24 hours.
Example 6- Long lasting deodorant Sprav
Figure imgf000008_0003
Figure imgf000009_0001
The formulation of Example 6 was tested on 9 people and gave deodorant protection of from 4-7 days whereas a control group had protection that lasted for less than 24 hours, and with either imidazolidinyl urea or tetrasodiun EDTA alone protection lasted 2-3 days.

Claims

1. A long lasting deodorant composition comprising a cosmetically acceptable base formulation containing from 0.1% to 30% of a compound selected from urea, imidazolidinyl urea or a cosmetically acceptable EDTA salt.
2. A composition as in claim I5 comprising between 0.3 to 10% urea and optionally 0.3 to 10% of a cosmetically acceptable EDTA salt.
3. A composition as in claim 1, comprising between 0.3 to 10% of imidazolidinyl urea and optionally 0.3 to 10% of a cosmetically acceptable EDTA salt.
4. A composition as in claim 1, comprising between 0.3 to 10% each of urea and imidazolidinyl urea and optionally 0.3 to 10% a cosmetically acceptable EDTA salt.
5. A composition as in claim 1, comprising between 0.1% to 5% each of urea and imidazolidinyl urea and optionally 0.1 to 5% of a cosmetically acceptable EDTA salt.
6. A composition as in any one of claims 1 to 5, wherein the EDTA salt is tetrasodium EDTA.
7. A composition as in any one of claims 1 to 6, further comprising between 1% to 8% ethylhexylglycerin.
8. A composition as in any one of claims 1 to 7, further comprising between 0.3% to 1% O-Cymen-5-ol.
9. A long lasting cream deodorant formulation comprising a composition as in any one of claims 1 to 8.
10. A long lasting stick deodorant formulation comprising a composition as in any one of claims 1 to 8.
11.A long lasting roll-on deodorant formulation comprising a composition as in any one of claims 1 to 8.
12. A long lasting spray deodorant formulation comprising a composition as in any one of claims 1 to 8.
G35417
PCT/IL2006/000566 2005-06-05 2006-05-14 Long acting deodorant composition WO2007132439A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IL2006/000566 WO2007132439A1 (en) 2006-05-14 2006-05-14 Long acting deodorant composition
JP2006156434A JP2006335761A (en) 2005-06-05 2006-06-05 Sustained release deodorizing composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2006/000566 WO2007132439A1 (en) 2006-05-14 2006-05-14 Long acting deodorant composition

Publications (1)

Publication Number Publication Date
WO2007132439A1 true WO2007132439A1 (en) 2007-11-22

Family

ID=36754299

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2006/000566 WO2007132439A1 (en) 2005-06-05 2006-05-14 Long acting deodorant composition

Country Status (1)

Country Link
WO (1) WO2007132439A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017216174A1 (en) * 2016-06-17 2017-12-21 Unilever Plc Deodorant products
WO2018036625A1 (en) * 2016-08-20 2018-03-01 Symrise Ag A preservative mixture

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5069896A (en) * 1989-06-01 1991-12-03 The Gillette Company Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing
US5162378A (en) * 1990-04-20 1992-11-10 Revlon Consumer Products Corporation Silicone containing water-in-oil microemulsions having increased salt content
JPH11253542A (en) * 1998-03-10 1999-09-21 Earth Chem Corp Ltd Deodorizing effect reinforcing agent and deodorizer using the same
US20010043911A1 (en) * 2000-03-31 2001-11-22 Kao Corporation Deodorant composition
WO2002047642A1 (en) * 2000-12-15 2002-06-20 Schering Ag Hypoallergenic and non-irritant skin care formulations
WO2002072018A2 (en) * 2001-03-09 2002-09-19 R.F. Technology Consultants, Inc. A cream-t0-powder dermatological composition
US6468512B1 (en) * 2000-11-22 2002-10-22 Avon Products, Inc. Gel compositions
US20030152644A1 (en) * 2001-10-23 2003-08-14 Shanta Modak Gentle-acting skin-disinfectants
US20050089488A1 (en) * 2003-10-27 2005-04-28 Kim Joo W. Deodorant composition with monocyclic, unsaturated sequiterpene alcohols and glyceryl monoalkyl ethers as synergistic active deodorant agents

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5069896A (en) * 1989-06-01 1991-12-03 The Gillette Company Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing
US5162378A (en) * 1990-04-20 1992-11-10 Revlon Consumer Products Corporation Silicone containing water-in-oil microemulsions having increased salt content
JPH11253542A (en) * 1998-03-10 1999-09-21 Earth Chem Corp Ltd Deodorizing effect reinforcing agent and deodorizer using the same
US20010043911A1 (en) * 2000-03-31 2001-11-22 Kao Corporation Deodorant composition
US6468512B1 (en) * 2000-11-22 2002-10-22 Avon Products, Inc. Gel compositions
WO2002047642A1 (en) * 2000-12-15 2002-06-20 Schering Ag Hypoallergenic and non-irritant skin care formulations
WO2002072018A2 (en) * 2001-03-09 2002-09-19 R.F. Technology Consultants, Inc. A cream-t0-powder dermatological composition
US20030152644A1 (en) * 2001-10-23 2003-08-14 Shanta Modak Gentle-acting skin-disinfectants
US20050089488A1 (en) * 2003-10-27 2005-04-28 Kim Joo W. Deodorant composition with monocyclic, unsaturated sequiterpene alcohols and glyceryl monoalkyl ethers as synergistic active deodorant agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 14 22 December 1999 (1999-12-22) *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017216174A1 (en) * 2016-06-17 2017-12-21 Unilever Plc Deodorant products
CN109310600A (en) * 2016-06-17 2019-02-05 荷兰联合利华有限公司 Deodorising product
US20190125640A1 (en) * 2016-06-17 2019-05-02 Conopco, Inc., D/B/A Unilever Deodorant products
AU2017285148B2 (en) * 2016-06-17 2019-05-16 Unilever Global Ip Limited Deodorant products
US10722435B2 (en) 2016-06-17 2020-07-28 Conopco, Inc. Deodorant products
EA036758B1 (en) * 2016-06-17 2020-12-17 Юнилевер Н.В. Deodorant products
CN109310600B (en) * 2016-06-17 2021-11-26 联合利华知识产权控股有限公司 Deodorant product
WO2018036625A1 (en) * 2016-08-20 2018-03-01 Symrise Ag A preservative mixture
US11400035B2 (en) 2016-08-20 2022-08-02 Symrise Ag Preservative mixture

Similar Documents

Publication Publication Date Title
JP3529093B2 (en) Combinations of compounds with bactericidal activity
US4331653A (en) Composition for a topical cream for curtailing bleeding and treating skin disorders
US4777034A (en) Compositions for counteracting the degradations and inconvenience of perspiration
JP2011513267A (en) Combinations of active ingredients and their use
EP2934121B1 (en) Improved antimicrobial compositions
WO2019086327A1 (en) Use of niacinamide for microbiome balancing
JP2007016045A (en) Cosmetic compositions containing rosemary extract and dha
US6426061B1 (en) Method and composition for preventing sweat-related odor
JP2007145771A (en) Antibacterial agent composition and deodorant agent
EP2175829A2 (en) Use of short-chain vicinal diols as agents having antiperspirant activity
JP3908244B2 (en) Male deodorant deodorant
KR20060020630A (en) Topical treatment of sebum related skin conditions
EP2385818B1 (en) Diols as antiperspirant agents
WO2007132439A1 (en) Long acting deodorant composition
JPH06509081A (en) Powdered body odor removal composition
JP4743704B2 (en) Antibacterial agent for bad odor bacteria, anti-odor agent and external preparation for skin containing the antibacterial agent
US10596092B2 (en) Deodorant composition and a method for preparing thereof
EP3226827B2 (en) Aluminium-free antiperspirant/deodorant compositions and method of preparing the same
JP2006335761A (en) Sustained release deodorizing composition
WO2021219763A1 (en) Ionic liquid as an antiperspirant
JP4293883B2 (en) Deodorant composition
EP3374032A1 (en) Anti-perspirant composition
JP4831960B2 (en) Composition for scalp and hair
JPS63174920A (en) Deodorant
JPH04257514A (en) Deodorant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06728349

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06728349

Country of ref document: EP

Kind code of ref document: A1